| Record Information |
| Version |
3.5 |
| Creation Date |
2006-05-18 03:02:16 -0600 |
| Update Date |
2013-05-15 15:17:19 -0600 |
| HMDB ID |
HMDB01937 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Salbutamol |
| Description |
Salbutamol is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD. It is 29 times more selective for beta2 receptors than beta1 receptors giving it higher specificity for pulmonary beta receptors versus beta1-adrenergic receptors located in the heart. Salbutamol is formulated as a racemic mixture of the R- and S-isomers. The R-isomer has 150 times greater affinity for the beta2-receptor than the S-isomer and the S-isomer has been associated with toxicity. This lead to the development of levalbuterol, the single R-isomer of salbutamol. However, the high cost of levalbuterol compared to salbutamol has deterred wide-spread use of this enantiomerically pure version of the drug. Salbutamol is generally used for acute episodes of bronchospasm caused by bronchial asthma, chronic bronchitis and other chronic bronchopulmonary disorders such as chronic obstructive pulmonary disorder (COPD). It is also used prophylactically for exercise-induced asthma.
Salbutamol or albuterol is a short-acting beta 2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma. -- Pubchem. |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (L)-albuterol
- 1-(Tert-butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol
- 2-(Tert-butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol
- 4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol
- Aerolin
- Albuterol
- Almotex
- alpha'-((Tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol
- alpha(Sup 1)-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol
- Alti-salbutamol
- Anebron
- Arubendol-salbutamol
- Asmadil
- Asmanil
- Asmasal
- Asmatol
- Asmaven
- Asmidon
- Asmol
- Asmol uni-dose
- Asthalin
- Broncho-spray
- Broncovaleas
- Bronter
- Bugonol
- Bumol
- Butamol
- Buto-asma
- Butohaler
- Butotal
- Butovent
- Buventol
- Cobutolin
- Dilatamol
- DL-albuterol
- DL-N-tert-butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine
- DL-salbutamol
- Farcolin
- Gerivent
- Grafalin
- Levalbuterol
- Libretin
- Medolin
- Mozal
- Novosalmol
- Parasma
- Pneumolat
- Proventil
- Proventil hfa
- Proventil inhaler
- R-Salbutamol
- Respax
- Respolin
- Sabutal
- Salamol
- Salbetol
- Salbron
- Salbu-basf
- Salbu-fatol
- Salbuhexal
- Salbulin
- Salbupur
- Salbusian
- Salbutalan
- Salbutamol free base
- Salbutamol sulphate
- Salbutamolum
- Salbutan
- Salbutol
- Salbuven
- Salbuvent
- Sallbupp
- Salmaplon
- Salomol
- Salvent
- Saventol
- Servitamol
- Spreor
- Sultanol
- Sultanol N
- Suprasma
- Suxar
- Theosal
- Tobybron
- Vencronyl
- Ventamol
- Ventilan
- Ventiloboi
- Ventodisks
- Ventolin
- Ventolin inhaler
- Ventolin rotacaps
- Ventoline
- Volare albuterol hfa
- Volare easi-breathe
- Volmax
- Zaperin
|
| Chemical Formula |
C13H21NO3 |
| Average Molecular Weight |
239.3107 |
| Monoisotopic Molecular Weight |
239.152143543 |
| IUPAC Name |
4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol |
| Traditional IUPAC Name |
salbutamol |
| CAS Registry Number |
18559-94-9 |
| SMILES |
CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1 |
| InChI Identifier |
InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3 |
| InChI Key |
NDAUXUAQIAJITI-UHFFFAOYSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Aromatic Homomonocyclic Compounds |
| Class |
Phenethylamines |
| Sub Class |
N/A |
| Other Descriptors |
- Organic Compounds
- phenylethanolamines(ChEBI)
- secondary amine(ChEBI)
|
| Substituents |
- 1,2 Aminoalcohol
- Benzyl Alcohol Derivative
- Phenol
- Phenol Derivative
- Primary Alcohol
- Secondary Alcohol
- Secondary Aliphatic Amine (Dialkylamine)
|
| Direct Parent |
Phenethylamines |
| Ontology |
| Status |
Expected and Not Quantified |
| Origin |
|
| Biofunction |
Not Available |
| Application |
Not Available |
| Cellular locations |
Not Available |
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
157 - 158 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
2.15e+00 g/L |
Not Available |
| LogP |
1.4 |
Not Available |
|
| Predicted Properties |
|
| Spectra |
|
Not Available
|
| Biological Properties |
| Cellular Locations |
Not Available
|
| Biofluid Locations |
Not Available
|
| Tissue Location |
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
Not Available |
| Abnormal Concentrations |
|
Not Available |
| Associated Disorders and Diseases |
| Disease References |
None |
| Associated OMIM IDs |
None |
| External Links |
| DrugBank ID |
DB01001  |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB022752 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
1999  |
| KEGG Compound ID |
C11770  |
| BioCyc ID |
Not Available |
| BiGG ID |
Not Available |
| Wikipedia Link |
Salbutamol  |
| NuGOwiki Link |
HMDB01937  |
| Metagene Link |
HMDB01937  |
| METLIN ID |
799  |
| PubChem Compound |
123600  |
| PDB ID |
68H  |
| ChEBI ID |
8746  |
| References |
| Synthesis Reference |
Not Available |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Fayon M, Dumas De La Roque E, Berger P, Begueret H, Ousova O, Molimard M, Marthan R: Increased relaxation of immature airways to beta2-adrenoceptor agonists is related to attenuated expression of postjunctional smooth muscle muscarinic M2 receptors. J Appl Physiol. 2005 Apr;98(4):1526-33. Epub 2004 Dec 3.
Pubmed: 15579574
- Yoshihara S, Yamada Y, Abe T, Kashimoto K, Linden A, Arisaka O: Long-lasting smooth-muscle relaxation by a novel PACAP analogue in human bronchi. Regul Pept. 2004 Dec 15;123(1-3):161-5.
Pubmed: 15518907
|